Clinical Scorecard: The Scleral Lens Vault: Overnight Scleral Lenses
At a Glance
| Category | Detail |
|---|---|
| Condition | Severe ocular surface disease |
| Key Mechanisms | Use of high-oxygen-permeable scleral lenses to protect the cornea and provide a pre-corneal fluid reservoir. |
| Target Population | Patients with severe ocular surface disease and recurrent epithelial erosion. |
| Care Setting | Ophthalmology clinics and specialized eye care settings. |
Key Highlights
- Overnight scleral lenses can promote healing in patients with severe ocular surface disease.
- Use of moxifloxacin in the lens bowl enhances healing of persistent epithelial defects.
- Daytime and overnight wear of scleral lenses has shown positive outcomes in clinical studies.
Guideline-Based Recommendations
Diagnosis
- Assess severity of ocular surface disease and corneal health.
Management
- Consider overnight therapeutic scleral lenses when other treatments are ineffective.
Monitoring & Follow-up
- Monitor corneal swelling and endothelial cell density during scleral lens wear.
Risks
- Potential for increased corneal swelling and microbial keratitis.
Patient & Prescribing Data
Patients with recurrent epithelial erosion and severe ocular surface disease.
Use of a regimen that includes both daytime and overnight wear of scleral lenses with moxifloxacin.
Clinical Best Practices
- Remove lenses for disinfection every 12 hours.
- Apply moxifloxacin HCL 0.5% to the lens reservoir before reapplication.
- Use preservative-free saline to top off the lens reservoir.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
